U.S. regulators launch new review of infant RSV therapies from Merck, Sanofi, and AstraZeneca amid scrutiny by Health Secretary Robert F. Kennedy Jr.
Australia bans under-16s from major social media platforms to protect kids online, while monitoring effects on behavior and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback